Back to top
more

Chemours (CC)

(Real Time Quote from BATS)

$11.97 USD

11.97
4,051,765

-0.66 (-5.23%)

Updated Aug 6, 2025 02:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (232 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Versum Materials (VSM) Q2 Earnings & Sales Beat Estimates

by Zacks Equity Research

Versum Materials (VSM) demonstrates strong performance in Q2 on the back of strong top-line growth in Materials and DS&S segments. The company also raises guidance for fiscal 2018.

    Zacks Equity Research

    Barrick (ABX) Inks Deal to Acquire 19.9% Stake in Midas Gold

    by Zacks Equity Research

    Barrick Gold (ABX) invests roughly $38.1 million in Midas Gold to acquire 19.9% stake in the company.

      Zacks Equity Research

      Zacks.com featured highlights include: Six Flags, SodaStream, WellCare Health, Chemours and LPL Financial

      by Zacks Equity Research

      Zacks.com featured highlights include: Six Flags, SodaStream, WellCare Health, Chemours and LPL Financial

        Zacks Equity Research

        Cash In On Driehaus Strategy With These 5 Momentum Stocks

        by Zacks Equity Research

        Driehaus strategy is a key investment approach for individuals with an inclination to take higher risk.

          Zacks Equity Research

          Has Chemours Company (CC) Outpaced Other Basic Materials Stocks This Year?

          by Zacks Equity Research

          Is Chemours Company (CC) Outperforming Other Basic Materials Stocks This Year?

            Zacks Equity Research

            Chemical Stock Q1 Earnings Due on May 3: DWDP, WLK, CC & PAH

            by Zacks Equity Research

            Earnings momentum for the chemical industry is expected to continue in Q1 as the fundamental driving factors remain in place.

              Zacks Equity Research

              Is a Beat in the Cards for WestRock (WRK) in Q2 Earnings?

              by Zacks Equity Research

              Despite cost headwinds, overall industry conditions and positive volume and pricing dynamics will aid WestRock's (WRK) earnings per share in Q2.

                Zacks Equity Research

                Zacks Value Investor Highlights: Chemourr, Dillard's, Macy's, Micron and Western Digital

                by Zacks Equity Research

                Zacks Value Investor Highlights: Chemourr, Dillard's, Macy's, Micron and Western Digital

                  Tracey Ryniec headshot

                  5 Tips for New Stock Investors

                  by Tracey Ryniec

                  Want to invest in stocks but unsure of how to get started?

                    Zacks Equity Research

                    Zacks.com highlights: Superior Uniform Group, H&E Equipment Services, Chemours, Applied Materials and Microchip Technology

                    by Zacks Equity Research

                    Zacks.com highlights: Superior Uniform Group, H&E Equipment Services, Chemours, Applied Materials and Microchip Technology

                      Sweta Killa headshot

                      5 Solid Dividend Growth Stocks Below $100

                      by Sweta Killa

                      Dividend growth stocks under $100 that could lead to a healthy portfolio with a greater scope of capital appreciation.

                        Zacks Equity Research

                        Zacks.com featured highlights include: Pilgrim's Pride, Insight Enterprises, Dorman, Chemours and Crown

                        by Zacks Equity Research

                        Zacks.com featured highlights include: Pilgrim's Pride, Insight Enterprises, Dorman, Chemours and Crown

                          Zacks Equity Research

                          Why Chemours Company (CC) Could Beat Earnings Estimates Again

                          by Zacks Equity Research

                          Chemours Company (CC) has seen a nice short-term history of beating earnings estimates, and looks poised to crush analyst expectations in its next earnings report as well.

                            Sanghamitra Saha headshot

                            Grab Market Momentum With 5 Top Rising P/E Stocks

                            by Sanghamitra Saha

                            Forget undervalued stocks, play these top-ranked stocks with rising P/E.

                              Swarup Gupta headshot

                              5 Great Basic Materials Stocks to Buy Ahead of Q1 Earnings

                              by Swarup Gupta

                              Prospects of a sustained period of growth and a pickup in inflation are likely to brighten the prospects of basic materials companies

                                Zacks Equity Research

                                The Zacks Analyst Blog Highlights: Pioneer Natural, Chemours, Louisiana-Pacific and Timken

                                by Zacks Equity Research

                                The Zacks Analyst Blog Highlights: Pioneer Natural, Chemours, Louisiana-Pacific and Timken

                                  Sweta Killa headshot

                                  Bet on These Sector ETFs & Stocks for Q1 Earnings

                                  by Sweta Killa

                                  We have highlighted one ETF and one stock from the sectors that could make great plays as the Q1 earnings season unfolds.

                                    Zacks Equity Research

                                    Why Chemours Company (CC) Could Be an Impressive Growth Stock

                                    by Zacks Equity Research

                                    Chemours Company (CC) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.

                                      Zacks Equity Research

                                      Is Chemours (CC) a Great Stock for Value Investors?

                                      by Zacks Equity Research

                                      Chemours (CC) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.

                                        Zacks Equity Research

                                        Top Ranked Value Stocks to Buy for April 4th

                                        by Zacks Equity Research

                                        Here are three stocks with buy rank and strong value characteristics for investors to consider today, April 3rd:

                                          Zacks Equity Research

                                          Zacks.com highlights: Chemours, Activision Blizzard, Jones Lang LaSalle, Avery Dennison and Applied Materials

                                          by Zacks Equity Research

                                          Zacks.com highlights: Chemours, Activision Blizzard, Jones Lang LaSalle, Avery Dennison and Applied Materials

                                            Zacks Equity Research

                                            Monsanto (MON) to Report Q2 Earnings: What's in the Cards?

                                            by Zacks Equity Research

                                            Higher sales and cost-control measures to boost Monsanto's (MON) earnings in second-quarter fiscal 2018. However, headwinds like input price volatility and industry rivalry remain a drag.

                                              Sweta Killa headshot

                                              5 Top Dividend Growth Stocks to Buy Amid Market Turmoil

                                              by Sweta Killa

                                              A history of year-over-year dividend growth leads to a healthy portfolio with greater scope of capital appreciation.

                                                Zacks Equity Research

                                                Chemours (CC) Looks Good: Stock Adds 5.4% in Session

                                                by Zacks Equity Research

                                                Chemours (CC) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

                                                  Tracey Ryniec headshot

                                                  5 Dirt Cheap 'Strong Buy' Stocks

                                                  by Tracey Ryniec

                                                  Single digit P/Es and rising earnings estimates make for a powerful combination.